References

  1. Bentley,D.R., Balasubramanian,S., Swerdlow,H.P., Smith,G.P., Milton,J., Brown,C.G., Hall,K.P., Evers,D.J., Barnes,C.L., Bignell,H.R. et al. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456, 53–59.
  2. LaFlamme, B. (2014) How we build a better tomato. Nature Gen. 
  3. Tanner, T.J., et al. (2016) Creation of the first ultra-low gluten barley (Hordeum vulgare L.) for coeliac and gluten-intolerant populations. Plant Biotechnology 14: 1139-1150.
  4. Franks, S.J., et al. (2014) Evolutionary and plastic responses to climate change in terrestrial plant populations. Evol. Appl. 7: 123–139.
  5. Gilbert, J., et al. (2003) Rebuilding Big Pharma’s Business Model. Windhover Information Inc. Vol 21: No. 10.
  6. Ashburn, T.T. and Thor, K.B. (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery 3: 673-683.
  7. Marcotte, R., et al. (2016) Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance. Cell 164:293-309.
  8. Shedure, J. and Lieberman, E. (2012) The expanding scope of DNA sequencing. Nature Biotechnology 30: 1084-1094.
  9. Grant, G.R., et al. (2007) Analysis and management of microarray gene expression data. Current Protocols in Molecular Biology, Chapter 19: Unit 19.6.